Blog
Contributors
Products
Subscribe
Contact Us
  • Search the Blog
  • Search for Topics
  • Search for Keywords
  • Search for Authors
1 min read

U.S. Navy to Deploy Floating Hospitals with Beckman Coulter Equipment on Board

BY Editorial Team |May 1 2020
Our hematology and microbiology systems will be on board U.S. naval ships providing general hospital relief during the COVID-19 outbreak.
U.S. Navy to Deploy Floating Hospitals with Beckman Coulter Equipment on Board

On March 18, President Trump announced that the U.S. Navy will deploy the USNS Comfort and Mercy Naval Floating Hospitals to New York and Los Angeles, respectively. These naval ships will provide general hospital relief, allowing local hospitals to focus their attention on COVID-19 cases. We’re proud to have hematology and microbiology systems on board to alleviate medical needs in those locations.

For more than 16 years, we have supplied the U.S. Navy with the medical equipment needed to support humanitarian relief operations both domestically and globally.

You can read more on the U.S. Department of Defense website.

News COVID-19
Editorial Team
Editorial Team
The Beckman Coulter editorial team brings you timely news and resources focused on elevating clinical laboratory performance and advancing patient care.
See all by Editorial Team

Related Articles

The evolution of high-sensitivity HIV diagnostic testing

The evolution of high-sensitivity HIV diagnostic testing

BY Dr. Lindsay Sun, M.D., M.S. |August 17 2026
5 min read
High-sensitivity diagnostic immunoassay testing is vital for meeting the increased HIV testing demands and enabling earlier treatment, which may curb viral transmissions by detecting infections sooner.
Read More
Expanding Integrated Testing at Oak Valley Health

Expanding Integrated Testing at Oak Valley Health

BY Natalie Taranto |August 17 2026
7 min read
DxC 500i Clinical Analyzer powers chemistry and immunoassay testing across multiple sites
Read More
What is driving the need to modernize STI diagnostics and surveillance?

What is driving the need to modernize STI diagnostics and surveillance?

BY Jeanie Chiu, MD |June 10 2026
5 min read
Effective management and public health surveillance for STIs require partnership with diagnostic laboratories to design and execute testing algorithms, confirm results, and report data.
Read More
Products
Support
Company Newsletter
Beckman Coulter Life Sciences
Stay Connected
Products
Support
Company
Newsletter
Beckman Coulter Life Sciences
Stay Connected


Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

 

© 2026 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. 

All trademarks used herein are the property of their respective owners.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.